Gen-Probe Tops Solvay Bid, Offers to Buy Innogenetics for $334M

Jun 04, 2008

NEW YORK (GenomeWeb News) – Gen-Probe has made a bid to buy the Belgian molecular diagnostics company Innogenetics for €215 million ($334 million) in cash, or €6.10 a share, besting an April offer of €5.75 a share from drug maker Solvay.

The offer is roughly 4.3 times Innogenetics’ diagnostic revenues of approximately €51 million in 2007.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Truth Seekers

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Quick Cell Edits

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

This Week in Science

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Genes for Success

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.

Main menu